VITROS IMMUNODIAGNOSTICS PRODUCTS MYOGLOBIN REAGENT PACK 6801042

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-07-20 for VITROS IMMUNODIAGNOSTICS PRODUCTS MYOGLOBIN REAGENT PACK 6801042 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[114944903] The investigation determined that a lower than expected myoglobin result was obtained from a level 1 biorad quality control fluid processed using vitros myoglobin reagent on a vitros eciq immunodiagnostic system. A definitive assignable cause for the event could not be determined with the information provided by the customer. Based on historical quality control results, a vitros myog lot 1315 performance issue is not a likely contributor to the event. Additionally, there is also no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the events as precision testing performed on the instrument was within ortho guidelines. The mdr is being submitted after the 30 day reporting date due to a technical issue with ortho? S mdr reporting system. Ortho was unable to electronically submit mdrs from 5 july 2018? 19 july 2018.
Patient Sequence No: 1, Text Type: N, H10


[114944904] The customer obtained a lower than expected myoglobin result from a non-vitros biorad level 1 quality control fluid processed using vitros immunodiagnostics products myoglobin (myog) reagent in combination a vitros eciq immunodiagnostic system. Biorad lot 29871 level 1 = 58. 1 ng/ml versus expected 70. 3 ng/ml. Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples. The unexpected vitros myoglobin results were generated from non-patient fluids, however the investigation cannot conclude that patient sample results were not affected and would not be affected if the event were to recur undetected. There was no allegation of patient harm as a result of the event. This report corresponds to ortho clinical diagnostics inc. Complaint number (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007111389-2018-00103
MDR Report Key7707154
Date Received2018-07-20
Date of Report2018-07-20
Date of Event2018-06-14
Date Mfgr Received2018-06-14
Device Manufacturer Date2018-03-09
Date Added to Maude2018-07-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO CLINICAL DIAGNOSTICS
Manufacturer StreetFELINDRE MEADOWS PENCOED
Manufacturer CityBRIDGEND, WALES CF355PZ
Manufacturer CountryUK
Manufacturer Postal CodeCF35 5PZ
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS IMMUNODIAGNOSTICS PRODUCTS MYOGLOBIN REAGENT PACK
Generic NameIN VITRO DIAGNOSTICS
Product CodeDDR
Date Received2018-07-20
Catalog Number6801042
Lot Number1315
Device Expiration Date2018-12-11
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2018-07-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.